
doi: 10.1038/nrdp.2016.16
pmid: 27159789
Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder, and increases in prevalence with increasing age and the number of cardiovascular comorbidities. AF is characterized by a rapid and irregular heartbeat that can be asymptomatic or lead to symptoms such as palpitations, dyspnoea and dizziness. The condition can also be associated with serious complications, including an increased risk of stroke. Important recent developments in the clinical epidemiology and management of AF have informed our approach to this arrhythmia. This Primer provides a comprehensive overview of AF, including its epidemiology, mechanisms and pathophysiology, diagnosis, screening, prevention and management. Management strategies, including stroke prevention, rate control and rhythm control, are considered. We also address quality of life issues and provide an outlook on future developments and ongoing clinical trials in managing this common arrhythmia.
Ablation Techniques, Medizin, Electric Countershock, Myocardial Ischemia, Dizziness, ADDITIONAL RISK-FACTOR, Propafenone, QUALITY-OF-LIFE, Heart Rate, Risk Factors, OBSTRUCTIVE SLEEP-APNEA, Atrial Fibrillation, RADIOFREQUENCY CATHETER ABLATION, FORM HEALTH SURVEY, Prevalence, Humans, PULMONARY VEIN ISOLATION, TERM-FOLLOW-UP, Heart Failure, Flecainide, CONGESTIVE-HEART-FAILURE, Aspirin, STROKE PREVENTION, Anticoagulants, RANDOMIZED CLINICAL-TRIAL, Stroke, Dyspnea, Hypertension, Quality of Life, [SHS] Humanities and Social Sciences, Platelet Aggregation Inhibitors, Sodium Channel Blockers
Ablation Techniques, Medizin, Electric Countershock, Myocardial Ischemia, Dizziness, ADDITIONAL RISK-FACTOR, Propafenone, QUALITY-OF-LIFE, Heart Rate, Risk Factors, OBSTRUCTIVE SLEEP-APNEA, Atrial Fibrillation, RADIOFREQUENCY CATHETER ABLATION, FORM HEALTH SURVEY, Prevalence, Humans, PULMONARY VEIN ISOLATION, TERM-FOLLOW-UP, Heart Failure, Flecainide, CONGESTIVE-HEART-FAILURE, Aspirin, STROKE PREVENTION, Anticoagulants, RANDOMIZED CLINICAL-TRIAL, Stroke, Dyspnea, Hypertension, Quality of Life, [SHS] Humanities and Social Sciences, Platelet Aggregation Inhibitors, Sodium Channel Blockers
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 217 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
